Liaw Wen Chao

Liaw Wen Chao

Auto-generated profile, based on publicly available information

Liaw Wen Chao

Universidade de São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
FSFernando Mendes Sant’aNna
Fernando Mendes Sant’aNna
RRRodrigo César Lima Resende
Rodrigo César Lima Resende
LSLucas Bonacossa Sant’aNna
Lucas Bonacossa Sant’aNna
SCSérgio Lívio Menezes Couceiro
Sérgio Lívio Menezes Couceiro
RPRomero Bonacossa Soares Pinto
Romero Bonacossa Soares Pinto
EKEugenijus Kaniusas
Eugenijus Kaniusas
COVID-19 is an infectious disease caused by the new coronavirus (SARS-CoV-2), which invades alveolar epithelial cells through angiotensin-2 converting enzyme (ACE2) receptors1 1 Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-80.e8. https://doi.org/10.1016/j.cell.2020.02.052 https://doi.org/10.1016/j.cell.2020.02.0... ,2 2 Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60. https://doi.org/10.1038/s41569-020-0360-5 https://doi.org/10.1038/s41569-020-0360-... . Infection is triggered by the binding of the spike protein (S) of SARS-CoV-1 or SARS-CoV-2 to ACE23 3 Costa IBSDS, Bittar CS, Rizk SI, Araújo Filho AE, Santos KAQ, Machado TIV, et al. The heart and COVID-19: what cardiologists need to know. Arq Bras Cardiol. 2020;114(5):805-16. https://doi.org/10.36660/abc.20200279 https://doi.org/10.36660/abc.20200279... and, through this binding, the virus enters the host cell, where ACE2 is later inactivated. As this enzyme is abundantly found in alveolar epithelial cells and in the myocardium, potentially serious damage can occur in the lungs and heart2 2 Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60. https://doi.org/10.1038/s41569-020-0360-5 https://doi.org/10.1038/s41569-020-0360-... ,4 4 Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, et al. COVID-19: a promising cure for the global panic. Sci Total Environ. 2020;725:138277. https://doi.org/10.1016/j.scitotenv.2020.138277 https://doi.org/10.1016/j.scitotenv.2020... .

10 November 2021 in Acupuncture in Medicine
Verified
Journal Article
Closed access
PDF file
LCLiaw Chao
Liaw Chao
AGAlexandre Sr Gonçalves
Alexandre Sr Gonçalves
ACAna Carolina P Campos
Ana Carolina P Campos
DADaniele V Assis
Daniele V Assis
RJRodrigo Jerônimo
Rodrigo Jerônimo
RPRosana Pagano
Rosana Pagano
Background: Neuropathic pain (NP) is a complex disease that remains challenging to treat. Low-frequency dense-and-disperse (DD) electroacupuncture (EA) has been used as adjuvant therapy for neuropathic pain; however, its analgesic effect decreases as stimulation time increases, or when it is repeatedly used. We hypothesized that a new frequency parameter could improve the effectiveness of EA, and aimed to compare the efficacy and duration of the analgesic effect between classic DD-EA and non-repetitive and non-sequential frequency (random frequency (RF)-EA) in neuropathic rats. Furthermore, the effect of RF-EA at local traditional acupuncture point locations versus auricular vagus nerve stimulation (aVNS) was evaluated. Methods: Male Wistar rats with peripheral neuropathy were subjected to a single session of DD-EA or RF-EA for 20 or 40 min at ST36 + GB34. An additional group of rats was treated with RF-EA for 20 min using aVNS at the appropriate ear point locations. Paw pressure test, von Frey filaments and spontaneous pain scores were evaluated. Sham-operated rats were used as controls. Results: In all, 20 min of RF-EA reversed hyperalgesia (for 24 h) and allodynia (for 8 h), showing a longer analgesic effect than DD-EA. Both RF-EA and DD-EA induced partial inhibition of spontaneous pain for 8 h. Forty minutes of DD-EA did not interfere with the NP phenomena; however, RF-EA induced significant long-term analgesia. aVNS induced an analgesic effect similar to local stimulation. Conclusion: This pilot study shows that RF-EA at both local traditional acupuncture point and auriculotherapy point locations induces long-lasting analgesia in neuropathic rats, and more effectively so than classical DD-EA.

1 January 2026 in Acta Cirurgica Brasileira
Verified
Journal Article
Open access
FGFelipe Giraldo Alvarez Gonçalves
Felipe Giraldo Alvarez Gonçalves
LCLiaw Wen Chao
Liaw Wen Chao
ESEmily Caroline da Fonseca Sampaio
Emily Caroline da Fonseca Sampaio
ANAdriano Augusto Domingos Neto
Adriano Augusto Domingos Neto
LALuiza Rafih Abud
Luiza Rafih Abud
WHWu Tu Hsing
Wu Tu Hsing
Purpose: This study evaluated electroacupuncture (EA) as adjunctive therapy after peripheral nerve repair in a rat model. Methods: Male Wistar rats underwent right sciatic nerve transection followed by neurorrhaphy and were randomized into EA or control groups. EA was performed twice weekly for 12 weeks. Sensory and motor recovery were assessed by nociceptive, mechanical, thermal, and sciatic functional index tests. Histological analyses evaluated Schwann cell and vascular densities, and gastrocnemius muscle weight was measured at euthanasia. Results: Sensory recovery was significantly greater in the EA group, with higher pain (3 [3–3.75] versus 2 [1–2], p = 0.02), pressure (2.5 [1.25–3] versus 0 [0–1], p = 0.009), and thermal sensitivity scores (2 [2–2.75] versus 0 [0–0], p = 0.02). Motor recovery and vascular density did not differ between groups. Distal Schwann cell density was significantly higher in the EA group (73.5 [67.4–74.1] versus 34.7 [34.5–38.4], p = 0.014). Gastrocnemius muscle weight was reduced in operated limbs in both groups, without intergroup differences. Conclusion: EA improved sensory recovery and increased distal Schwann cell density, supporting its potential as an adjunctive therapy after peripheral nerve repair.